Navigation Links
CDC Issues Guidance on Daily Pill to Prevent Infection With HIV
Date:1/27/2011

By Amanda Gardner
HealthDay Reporter

THURSDAY, Jan. 27 (HealthDay News) -- U.S. health authorities on Thursday issued an "interim guidance" to help doctors and patients using Truvada, the once-a-day combination pill that was shown in November to help prevent the spread of HIV in high-risk individuals.

The guidance, from experts at the U.S. Centers for Disease Control and Prevention, stresses that only gay and bisexual men at high risk for contracting the virus -- the same population included in the study -- should use the pill.

When used as a preventive agent, the medication should only be given to men who are currently HIV-negative and only as part of a larger prevention plan that includes testing for other sexually transmitted diseases, counseling and using condoms faithfully.

"While we think this is really a very important new tool in HIV prevention, it has only been proven safe and effective with men who have sex with men, so at this point we don't feel we have the information to discuss its use for anyone other than [this group]," said Dr. Dawn Smith, lead author of the new guidance, which appears in the Jan. 28 issue of the CDC journal Morbidity and Mortality Weekly Report.

Even for highly sexually active gay and bisexual men, "it's not the first line of prevention," Smith said. "It's meant for men who are unable to successfully, consistently use standard methods of reducing their risk of acquiring HIV."

In essence, Truvada is "meant to function as a safety net in addition to those methods. So if a man can't use condoms consistently then maybe [Truvada] would be helpful while they improve condom use," Smith said.

Truvada is a combination of two anti-HIV drugs, emtricitabine (Emtriva) and tenofovir (Viread), included in a once-a-day pill. The pill is already available by prescription as a treatment for HIV infection.

A study published Nov. 25 in the New England Journal of Medicine found that it cut the risk of HIV infection by almost 44 percent in those at highest risk for contracting the virus, namely sexually active gay and bisexual men.

The risk reduction climbed to nearly 73 percent among study participants who took the pill 90 percent of the time, the researchers added.

Both the treatment and the control group in the study also received intensive counseling on safe sex practices and were given condoms (about 500,000 condoms were distributed throughout the course of the trial).

Men in the study reported having had an average of 18 sexual partners in the previous 12 weeks.

Another expert agreed, however, that Truvada is not meant to supplant the condom.

"There has always been a concern that people will see this as an either/or proposition [pill or condom] but it's clearly 'and,'" said Dr. Michael Horberg, director of HIV/AIDS at Kaiser Permanente Health Plan.

"A lot of organizations such as ours have strategized how best to interpret the study results and we totally agree with the considerations of the CDC," he said.

At the time the study was released, the CDC issued "immediate cautions" with similar but less specific recommendations.

This interim report includes more specific information, including getting tested and receiving safe-sex counseling every two to three months while on the medication.

The guidance is intended to fill a gap until formal U.S. Public Health Service guidelines are issued hopefully later this year, Smith said.

"We're working on the first draft of the formal guidelines but, because they involve other Health & Human Services agencies and a public comment process, we don't expect them until later this year," said Smith, who is a biomedical intervention implementation officer at the U.S. National Center for HIV/AIDS Prevention, part of the CDC.

One cloud in the silver lining: A year's worth of Truvada totals more than $10,000 a year, and that is the discounted rate. Generic versions are available in some countries (not the United States) for as low as $500 a year.

More information

There's more on HIV/AIDS at the CDC.

SOURCES: Dawn Smith, M.D., biomedical intervention implementation officer, National Center for HIV/AIDS Prevention, CDC; Michael Horberg, M.D., director, HIV/AIDS, Kaiser Permanente Health Plan; Jan. 28, 2011, Morbidity and Mortality Weekly Report


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
2. American Red Cross Issues One-Month Progress Report for Haiti Earthquake
3. New study suggests stem cells sabotage their own DNA to produce new tissues
4. One in Two Children Has Chronic Health Issues
5. The Ensign Group Reports Fourth Quarter 2009 Adjusted Earnings of $0.43 Per Share; Issues 2010 Guidance
6. FDA Issues Warning on Key Asthma Drugs
7. Toyota Recalls Raise Awareness of Vehicle Safety Issues, Risks of Accidents from Driving Defective Automobiles
8. CHIME Issues Comments on EHR Incentive Program
9. Americans Weigh in on Skincare Issues
10. Illinois State Senator Cullerton Recognized for Advocacy Work on Mental Health Issues
11. ATS issues statement on disorder of respiratory and autonomic nervous system regulation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CDC Issues Guidance on Daily Pill to Prevent Infection With HIV
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: